Lexeo Therapeutics, Inc.

• Lexeo Therapeutics to host event on clinical me...
  Pluang · 19 Oct 2026
• Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
  The Manila Times · 19 Oct 2026
• JPMorgan reports ownership above 5% in Lexeo Therapeutics (LXEO).
  Stock Titan · 13 Oct 2026
• Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
  GlobeNewswire · 08 Oct 2026
• Lexeo Therapeutics to present at Chardan Health...
  Pluang · 08 Oct 2026
• Stifel reiterates Buy rating on Lexeo Therapeutics stock at $17 By Investing.com
  Investing.com South Africa · 05 Oct 2026
• Lexeo Therapeutics (NasdaqGM:LXEO) Stock Forecast & Analyst Predictions
  Simply Wall Street · 05 Oct 2026
• Lexeo Therapeutics Announces Oral Presentation of LX2006 at
  GlobeNewswire · 01 Oct 2026
• Lexeo Therapeutics at Stifel 2026 Virtual Cardiometabolic Forum: pipeline push
  Investing.com · 30 Sep 2026
• Lexeo expands Friedreich ataxia pipeline with Mantle deal
  PharmaTimes · 29 Sep 2026
• Form 8K Lexeo Therapeutics Inc For: 29 September By Investing.com
  Investing.com UK · 29 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →